Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Aprogen, Inc. covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, company history, capital changes, and management discussions, which are characteristic of a comprehensive interim financial report. It is not an announcement or a certification, but the full report itself. 9M 2022
2022-11-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting' (주주총회소집공고) for the company Aprogen. It includes details about the meeting date, location, agenda items (such as director approval and capital reduction), and management's report on business activities (Section III). This type of document is a formal proxy statement/notice sent to shareholders to inform them of an upcoming meeting and provide necessary background information for voting. In the provided classification schema, this fits best under 'Proxy Solicitation & Information Statement' (PSI).
2022-11-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Aprogen, which includes details on the meeting date, agenda items (such as board appointments and capital reduction), and management reference materials (business overview, industry analysis, and board activity). This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-11-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Aprogen, which includes details about the meeting date, agenda items (such as director approval and capital reduction), and management reference materials. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-11-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Aprogen, which includes details on agenda items, date changes, and management information. While it contains governance and business overview sections, the primary purpose is to notify shareholders of an upcoming meeting and the specific items to be voted upon (including capital reduction). This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to exercise their voting rights.
2022-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure for insiders (directors, officers, and major shareholders) to report changes in their shareholdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership changes.
2022-11-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.